TL;DR
- iPledge is the FDA's mandatory risk-management program for isotretinoin (Accutane).
- Every U.S. patient — male or female — must enroll before starting and check in every month.
- The pickup window is 7 days after each monthly check-in. Miss it and you wait for the next cycle.
- Patients who can get pregnant complete two negative pregnancy tests separated by 19 days before each refill.
- FDA's August 9, 2026 update made several changes — including elimination of the 19-day lockout and the in-office pregnancy test requirement.
- TGIC's iPledge concierge tracks every window, test, and refill for you.
What iPledge is, in plain English
iPledge is the FDA-mandated program that controls who can receive isotretinoin (Accutane) and when. It exists because isotretinoin causes severe, predictable birth defects if taken during pregnancy. The program is the FDA's way of making sure no patient starts Accutane pregnant and no patient becomes pregnant during treatment.
Three parties have to participate every month: the patient, the prescriber, and the pharmacy. All three log into iPledge, confirm the patient is still eligible to receive the drug, and only then does the pharmacy release the next month's supply.
The monthly window
After each monthly dermatologist check-in, iPledge opens a 7-day pickup window. The patient confirms answers to the iPledge education questions, the prescriber authorizes, and the pharmacy dispenses — all within that 7-day window. Miss it and the prescription voids. You don't lose your spot in the program, but you lose that month of treatment.
This is the single most frustrating mechanic in the program. It's why dermatologists who don't specialize in Accutane often refuse to prescribe it: the operational load is real, and missed windows mean delayed treatment.
Pregnancy testing cadence
Patients who can get pregnant complete pregnancy testing in two parts:
- A baseline test before starting Accutane, separated from a second confirmatory test by 19 days.
- A negative test every month during treatment, completed within the 7-day window before the next refill.
- A final test 30 days after the last dose.
Patients who cannot get pregnant complete a monthly attestation instead — confirming they understand the risks and the contraception requirements (or non-applicability).
What changed August 9, 2026
The FDA's August 9, 2026 update to the iPledge REMS program made several changes:
- 19-day lockout eliminated. The mandatory wait between baseline pregnancy tests was removed.
- CLIA-waived in-office test no longer required. Lab-based pregnancy tests qualify. This was a major barrier to telehealth Accutane access.
- Monthly window structure revised. Cleaner rules around when the window opens, closes, and resets.
- Patient education materials updated. Simpler language, fewer redundant attestations.
- Prescriber and pharmacy workflow streamlined. Fewer manual REMS steps for participating clinics.
TGIC's iPledge concierge is built around the new rules. Patients starting after August 9 follow the updated cadence; patients mid-course transition with their dermatologist.
What happens if you miss a window
The current month's prescription voids. You wait for the next monthly cycle to open, complete the check-in and (if applicable) a new pregnancy test, and resume. You don't lose your overall eligibility — you lose a month of treatment.
The most common reason patients miss windows: they didn't know the window was open, or didn't know when it was about to close. That's the operational chaos TGIC's concierge exists to prevent. Every window-open and window-closing event triggers an alert, and you can see the live window state in your dashboard.
Common questions
What is iPledge and why does Accutane require it?
iPledge is the FDA's risk-management program for isotretinoin (Accutane). It exists because isotretinoin causes severe birth defects if taken during pregnancy, so every U.S. patient — male or female — must enroll before starting and check in every month of treatment. iPledge tracks pregnancy tests, monthly authorization windows, and pharmacy pickup deadlines.
How does the iPledge monthly window work?
The iPledge monthly window is a 7-day pickup window that opens after each monthly check-in. Patients who can get pregnant complete two negative pregnancy tests separated by 19 days before each refill; patients who can't get pregnant complete a monthly attestation. Miss the 7-day window and the prescription resets — you wait for the next cycle. TGIC's iPledge concierge tracks every window for you so you don't lose a month.
What happens if I miss my iPledge window?
If you miss your iPledge 7-day pickup window, the current prescription voids and you wait for the next monthly window to open. You don't lose your spot in the program, but you lose that month of treatment. TGIC sends window-open alerts, refill reminders, and a heads-up before the window closes — keeping the chaos out of the program is the whole reason the concierge exists.
Did iPledge rules change in 2026?
Yes. The FDA's August 9, 2026 update to the iPledge REMS program made several changes — including elimination of the 19-day lockout between baseline pregnancy tests, removal of the CLIA-waived in-office pregnancy test requirement, and a revised monthly window structure. TGIC's iPledge concierge is built around the updated rules. Patients starting after August 9 follow the new cadence.
Keep reading
Cost and insurance
Pricing for The Clear Course, what insurance covers, how prescriptions are billed, HSA and FSA receipts, and what labs cost.
Accutane (isotretinoin)
How Accutane works through TGIC, low-dose protocols, side effects, course length, and how it compares to topicals like tretinoin.
States and eligibility
Where TGIC operates, who can enroll, conditions covered, and how teen consent works.
How it works
The dermatologist, the quiz, results timeline, cancel terms, HIPAA, and how TGIC differs from other online services.